Skip to main content

FDA Issues To Recall Another Heartburn Drug

FDA Issues To Recall Another Heartburn Drug

FDA Issues To Recall Another Heartburn Drug

Introduction

On April 15, the FDA announced to recall Nizatidine Oral Solution, after finding the presence of the cancer-causing chemical N-Nitrosodimethylamine (NDMA).

Amneal Pharmaceuticals, following the announcement, declared for a nationwide recall of the generic oral heartburn medication nizatidine.

A similar nationwide recall was made on Zantac after the active pharmaceutical ingredient, ranitidine was found to produce high levels of NDMA when in storage. The presence of NDMA in Zantac surfaced in September 2019, when an independent pharmacy found high levels of the carcinogenic chemical in all doses and lots of the widely used heartburn drug.

More than 140 product liability lawsuits and class action cases have been filed throughout the federal court system, each raising similar allegations that the exposure to the active ingredient in Zantac, causes bladder cancer, kidney cancer, colorectal cancer, stomach cancer, and other forms of cancer.

The lawsuits are consolidated and centralized before U.S. District Judge Robin L in Florida under MDL No: 2924, for coordinated discovery and pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.